NVCT vs PDD · $304.5M cap vs P/E 8.4, rev $61.75B
Nuvectis Pharma Inc (NVCT) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
NVCT does not have a complete income-statement cache yet.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
NVCT currently screens at market cap $304.5M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the NVCT and PDD stock pages for the full models.
Not investment advice.